Quantcast

Latest Regenerative biomedicine Stories

2011-04-07 06:30:00

MENLO PARK, Calif., April 7, 2011 /PRNewswire/ -- BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced data supporting the use of VitaKine® Platelet Cell Therapy (PCT) as a promising treatment for heart attack patients. The results of a preclinical cardiac study were presented at the 2nd Annual Translational Regenerative Medicine Forum in Washington, D.C. Platelet-Rich Plasma (PRP), a...

2011-03-16 09:00:00

TAIZHOU, China, March 16, 2011 /PRNewswire-Asia/ -- Beike Biotechnology Co. Ltd. ("Beike") (http://www.beikebiotech.com), China's leading stem cell research and regenerative medicine company, announced an agreement with USA-based ThermoGenesis Corp. to employ new, cutting edge stem cell processing and storage technology across its adult stem cell collection, processing, and archive platform. Under the arrangement, which underscores Beike's strategic commitment to upgrading its current...

2011-03-07 16:00:00

NEW YORK, March 7, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S. and China, announced today that Dr. Ian Zhang, PhD, MBA, President and Managing Director of NeoStem (China), Inc. will present at the Rodman & Renshaw Annual China Investment Conference on Tuesday, March 8, 2011. The Conference, which runs from March 6 - 8, 2011, is being held at Le Royal Meridien Shanghai, at 789 Nanjing Road East in Shanghai,...

2011-01-27 00:02:58

International regenerative medicine expert Dr. Christopher J. Centeno teams up with healthy aging global leader Cenegenics® Medical Institute to evaluate stem cell programs for medical best practices Las Vegas, Nevada (Vocus/PRWEB) January 26, 2011 Cenegenics® Medical Institute, the global leader in age management medicine, is announcing its recent partnership with international expert and specialist in regenerative medicine Christopher J. Centeno, MD to make stem cell...

2011-01-18 13:52:00

NEW YORK, Jan. 18, 2011 /PRNewswire/ -- StemSave, the market leader in the field of dental stem cell recovery and cryo-preservation, today announced Dr. George T.-J. Huang, DDS, MSD, DSc, the Chair and Herbert Schilder Professor in Endodontics and Director of the Postgraduate Program in Endodontics of Boston University's Henry M. Goldman School of Dental Medicine, joined its Science Advisory Council. Dr. Huang will support and advise StemSave as it continues to expand its easy-to-use stem...

2011-01-18 05:00:00

BOTHELL, Wash., Jan. 18, 2011 /PRNewswire/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS) announced today that it has significantly increased its financial support for several key organizations in the regenerative medicine industry. The worldwide regenerative medicine market is comprised of nearly 1,000 commercial companies and hospitals, which are developing cell and tissue-based products and therapies to treat cancer, heart disease, diabetes, neurologic disorders, movement...

2011-01-17 12:23:15

Researchers from Baylor College of Medicine and Rice University have broken one of the major roadblocks on the path to growing transplantable tissue in the lab: They've found a way to grow the blood vessels and capillaries needed to keep tissues alive. The new research is available online and due to appear in the January issue of the journal Acta Biomaterialia. Leading problem in regenerative medicine "The inability to grow blood-vessel networks -- or vasculature -- in lab-grown tissues is...

2011-01-03 07:00:00

CLEVELAND, Jan. 3, 2011 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI). JVS-100 encodes Stromal-cell Derived Factor 1 (SDF-1), which has been shown in several pre-clinical...

2010-12-29 00:01:19

Steven Victor MD CEO ReGen BioSciences, a company operating and marketing upscale Rejuvenation Centers and Tissue Processing Centers that provides stem cell rejuvenation, adipose stem cell separation and aesthetic treatments appeared on the Fox News website December 8, 2010 the "Futuristic Facelift" New York, NY (PRWEB) December 28, 2010 Steven Victor MD CEO of Regen Biosciences appears on Fox News to discuss the use of fat stem cells for cosmetic uses Steven Victor MD CEO ReGen...

2010-12-09 06:00:00

Reduces Manual Laboratory Research Processes from Hours to Seconds; Saving Significant Time and Money TSX VENTURE: HTL BEVERLY, MA and TORONTO, Dec. 9 /PRNewswire/ - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of advanced laser systems for the regenerative medicine and stem cell research markets, today announced the launch of its new Stiletto(TM) laser system.  The Stiletto(TM) laser system has broad applications for research with a variety of cells, allowing the...


Latest Regenerative biomedicine Reference Libraries

The Axolotl, Ambystoma mexicanum
2014-02-03 08:59:54

Axolotl (Ambystoma mexicanum) may also be referred to as the Mexican salamander or the Mexican walking fish. The Axolotl is a member of the Ambystomatidae family and although its common name may suggest it is a fish, it is an amphibian. Axolotl are found exclusively in Mexico. The species situates, near Mexico City, on the bottom of Xochimilco’s lakes. Unlike most salamanders, Axolotl keep its larval features throughout its entire life and very rarely ever emerge from water. A condition...

More Articles (1 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'